The number of CD56+ cells/mm2 tumour tissue decreased in all three patients of the control group after neoadjuvant chemotherapy, while it remained stable in the exercise group (Fig. 5a, Supplementary Fig. 6a). The gene discussed is NCAM1; the disease is neoplasm.